Login to MyKarger

New to MyKarger? Click here to sign up.



Login with Facebook

Forgot your password?

Authors, Editors, Reviewers

For Manuscript Submission, Check or Review Login please go to Submission Websites List.

Submission Websites List

Institutional Login
(Shibboleth or Open Athens)

For the academic login, please select your country in the dropdown list. You will be redirected to verify your credentials.

Neurodegenerative Diseases

Vol. 7, No. 1-3, 2010

Issue release date: April 2010

Alzheimer's and Parkinson's Diseases: Advances, Concepts and New Challenges

9th International Conference AD/PD, Prague, March 2009: Proceedings

See also ISBN 978-3-8055-9358-8 for more details
Add all to MyReading List
Special Section
1

Title Page / Table of Contents

Neurodegenerative Dis 2010;7:1–4 (DOI:10.1159/000313305)
Free Access
 
5

Preface

Windisch M. · Nitsch R. · Fisher A. · Hanin I.
Neurodegenerative Dis 2010;7:5 (DOI:10.1159/000283473)
Free Access
History of Dementia Research
6

History of Dementia Research in Bohemia and Middle Europe

Kalvach P. · Kalvach Z.
Neurodegenerative Dis 2010;7:6–9 (DOI:10.1159/000283474)
Biology of Neurodegeneration
10

Dissecting Toxicity of Tau and β-Amyloid

Götz J. · Lim Y.-A. · Ke Y.D. · Eckert A. · Ittner L.M.
Neurodegenerative Dis 2010;7:10–12 (DOI:10.1159/000283475)
13

Tau Kinase I Overexpression Induces Dentate Gyrus Degeneration

Avila J. · Gómez de Barreda E. · Engel T. · Pérez M. · Martín-Maestro P. · Fuster-Matanzo A. · Goñi-Oliver P. · Lucas J.J. · Hernández F.
Neurodegenerative Dis 2010;7:13–15 (DOI:10.1159/000283476)
16

Possible Role of Tau in Mediating Pathological Effects of apoE4 in vivo prior to and following Activation of the Amyloid Cascade

Inbar D. · Belinson H. · Rosenman H. · Michaelson D.M.
Neurodegenerative Dis 2010;7:16–23 (DOI:10.1159/000283477)
24

Transition of Tau Protein from Disordered to Misordered in Alzheimer’s Disease

Kovacech B. · Skrabana R. · Novak M.
Neurodegenerative Dis 2010;7:24–27 (DOI:10.1159/000283478)
28

‘Prion-Like’ Propagation of Mouse and Human Tau Aggregates in an Inducible Mouse Model of Tauopathy

Sydow A. · Mandelkow E.-M.
Neurodegenerative Dis 2010;7:28–31 (DOI:10.1159/000283479)
32

Are Aβ and Its Derivatives Causative Agents or Innocent Bystanders in AD?

Robakis N.K.
Neurodegenerative Dis 2010;7:32–37 (DOI:10.1159/000266476)
Free Access
38

Neuroinflammation – An Early Event in Both the History and Pathogenesis of Alzheimer’s Disease

Eikelenboom P. · van Exel E. · Hoozemans J.J.M. · Veerhuis R. · Rozemuller A.J.M. · van Gool W.A.
Neurodegenerative Dis 2010;7:38–41 (DOI:10.1159/000283480)
42

Analysis of APL1β28, a Surrogate Marker for Alzheimer Aβ42, Indicates Altered Precision of γ-Cleavage in the Brains of Alzheimer Disease Patients

Okochi M. · Tagami S. · Takeda M.
Neurodegenerative Dis 2010;7:42–45 (DOI:10.1159/000283481)
46

Expression of Familial Alzheimer’s Disease-Linked Human Presenilin 1 Variants Impair Enrichment-Induced Adult Hippocampal Neurogenesis

Veeraraghavalu K. · Choi S.H. · Sisodia S.S.
Neurodegenerative Dis 2010;7:46–49 (DOI:10.1159/000283482)
50

p53 Is Regulated by and Regulates Members of the γ-Secretase Complex

Checler F. · Dunys J. · Pardossi-Piquard R. · Alves da Costa C.
Neurodegenerative Dis 2010;7:50–55 (DOI:10.1159/000283483)
56

Amyloid-β-Derived Diffusible Ligands Cause Impaired Axonal Transport of Mitochondria in Neurons

Wang X. · Perry G. · Smith M.A. · Zhu X.
Neurodegenerative Dis 2010;7:56–59 (DOI:10.1159/000283484)
Free Access
60

Acetylcholinesterase Variants in Alzheimer’s Disease: From Neuroprotection to Programmed Cell Death

Greenberg D.S. · Toiber D. · Berson A. · Soreq H.
Neurodegenerative Dis 2010;7:60–63 (DOI:10.1159/000285507)
64

Neuroprotective and Neurotoxic Phenotypes of Activated Microglia in Neonatal Mice with Respective MPTP- and Ethanol-Induced Brain Injury

Sawada H. · Suzuki H. · Nagatsu T. · Sawada M.
Neurodegenerative Dis 2010;7:64–67 (DOI:10.1159/000285508)
68

LRRK2 and the Stress Response: Interaction with MKKs and JNK-Interacting Proteins

Hsu C.H. · Chan D. · Wolozin B.
Neurodegenerative Dis 2010;7:68–75 (DOI:10.1159/000285509)
Free Access
76

Misframed Proteins and Neurodegeneration: A Novel View on Alzheimer’s and Parkinson’s Diseases

Dennissen F.J.A. · Kholod N. · Steinbusch H.W.M. · Van Leeuwen F.W.
Neurodegenerative Dis 2010;7:76–79 (DOI:10.1159/000285510)
80

Impaired Neurotransmitter Release in Alzheimer’s and Parkinson’s Diseases

Shen J.
Neurodegenerative Dis 2010;7:80–83 (DOI:10.1159/000285511)
Free Access
84

Stem Cell Biology in the Study of Pathological Conditions

Sugaya K.
Neurodegenerative Dis 2010;7:84–87 (DOI:10.1159/000285512)
Disease Models
88

Possible Involvement of Transthyretin in Hippocampal β-Amyloid Burden and Learning Behaviors in a Mouse Model of Alzheimer’s Disease (TgCRND8)

Doggui S. · Brouillette J. · Chabot J.-G. · Farso M. · Quirion R.
Neurodegenerative Dis 2010;7:88–95 (DOI:10.1159/000285513)
96

Early-Stage Inflammation and Experimental Therapy in Transgenic Models of the Alzheimer-Like Amyloid Pathology

Cuello A.C. · Ferretti M.T. · Leon W.C. · Iulita M.F. · Melis T. · Ducatenzeiler A. · Bruno M.A. · Canneva F.
Neurodegenerative Dis 2010;7:96–98 (DOI:10.1159/000285514)
99

Transgenic Zebrafish as a Novel Animal Model to Study Tauopathies and Other Neurodegenerative Disorders in vivo

Paquet D. · Schmid B. · Haass C.
Neurodegenerative Dis 2010;7:99–102 (DOI:10.1159/000285515)
103

Generation of Tau Aggregates and Clearance by Autophagy in an Inducible Cell Model of Tauopathy

Wang Y. · Krüger U. · Mandelkow E. · Mandelkow E.-M.
Neurodegenerative Dis 2010;7:103–107 (DOI:10.1159/000285516)
108

Silencing/Overexpressing Selected Genes as a Model of Sporadic Parkinson’s Disease

Fishman-Jacob T. · Youdim M.B.H. · Mandel S.A.
Neurodegenerative Dis 2010;7:108–111 (DOI:10.1159/000285517)
Relationship Between Cerebrovascular Lesions and Primary Neurodegenerative Diseases
112

Prevalence and Impact of Cerebrovascular Lesions in Alzheimer and Lewy Body Diseases

Jellinger K.A.
Neurodegenerative Dis 2010;7:112–115 (DOI:10.1159/000285518)
116

The Vascular Hypothesis of Alzheimer’s Disease: Bench to Bedside and Beyond

de la Torre J.C.
Neurodegenerative Dis 2010;7:116–121 (DOI:10.1159/000285520)
122

Vascular Dementia and Alzheimer’s Disease – Are We in a Dead-End Road?

Cavalieri M. · Enzinger C. · Petrovic K. · Pluta-Fuerst A. · Homayoon N. · Schmidt H. · Fazekas F. · Schmidt R.
Neurodegenerative Dis 2010;7:122–126 (DOI:10.1159/000285521)
127

Vascular Contribution to Dementia in Parkinson’s Disease

Korczyn A.D.
Neurodegenerative Dis 2010;7:127–130 (DOI:10.1159/000285522)
Imaging, Biomarkers, Genetics and Diagnostic Markers
131

Early Detection of Alzheimer’s Disease with PET Imaging

Berti V. · Osorio R.S. · Mosconi L. · Li Y. · De Santi S. · de Leon M.J.
Neurodegenerative Dis 2010;7:131–135 (DOI:10.1159/000289222)
Free Access
136

Amyloid Imaging in Early Detection of Alzheimer’s Disease

Nordberg A.
Neurodegenerative Dis 2010;7:136–138 (DOI:10.1159/000289223)
139

Inability of Plasma and Urine F2A-Isoprostane Levels to Differentiate Mild Cognitive Impairment from Alzheimer’s Disease

Mufson E.J. · Leurgans S.
Neurodegenerative Dis 2010;7:139–142 (DOI:10.1159/000289224)
Free Access
143

Increased CD44 Gene Expression in Lymphocytes Derived from Alzheimer Disease Patients

Uberti D. · Cenini G. · Bonini S.A. · Barcikowska M. · Styczynska M. · Szybinska A. · Memo M.
Neurodegenerative Dis 2010;7:143–147 (DOI:10.1159/000289225)
148

Human Analogue of the Morris Water Maze for Testing Subjects at Risk of Alzheimer’s Disease

Laczó J. · Andel R. · Vyhnalek M. · Vlcek K. · Magerova H. · Varjassyova A. · Tolar M. · Hort J.
Neurodegenerative Dis 2010;7:148–152 (DOI:10.1159/000289226)
153

Social Odor Recognition: A Novel Behavioral Model for Cognitive Dysfunction in Parkinson’s Disease

Monaghan M.M. · Leddy L. · Sung M.-L.A. · Albinson K. · Kubek K. · Pangalos M.N. · Reinhart P.H. · Zaleska M.M. · Comery T.A.
Neurodegenerative Dis 2010;7:153–159 (DOI:10.1159/000289227)
160

Cognitive Event-Related Potentials and Oscillations in the Subthalamic Nucleus

Rektor I. · Baláž M. · Bočková M.
Neurodegenerative Dis 2010;7:160–162 (DOI:10.1159/000289228)
163

Oophorectomy, Menopause, Estrogen, and Cognitive Aging: The Timing Hypothesis

Rocca W.A. · Grossardt B.R. · Shuster L.T.
Neurodegenerative Dis 2010;7:163–166 (DOI:10.1159/000289229)
Free Access
167

Pharmacogenomic Protocols in CNS Disorders and Dementia

Cacabelos R.
Neurodegenerative Dis 2010;7:167–169 (DOI:10.1159/000289230)
170

Common Variant in GRN Is a Genetic Risk Factor for Hippocampal Sclerosis in the Elderly

Dickson D.W. · Baker M. · Rademakers R.
Neurodegenerative Dis 2010;7:170–174 (DOI:10.1159/000289231)
Free Access
175

Leucine-Rich Repeat Kinase 2 Gene-Associated Disease: Redefining Genotype-Phenotype Correlation

Wider C. · Dickson D.W. · Wszolek Z.K.
Neurodegenerative Dis 2010;7:175–179 (DOI:10.1159/000289232)
Free Access
Treatment and Prevention
180

Lipid-Lowering Treatment Is Related to Decreased Risk of Dementia: A Population-Based Study (FINRISK)

Solomon A. · Sippola R. · Soininen H. · Wolozin B. · Tuomilehto J. · Laatikainen T. · Kivipelto M.
Neurodegenerative Dis 2010;7:180–182 (DOI:10.1159/000295659)
183

Cholesterol and Cognitive Performance in Normal Controls and the Influence of Elective Statin Use after Conversion to Mild Cognitive Impairment: Results in a Clinical Trial Cohort

Sparks D.L. · Kryscio R.J. · Connor D.J. · Sabbagh M.N. · Sparks L.M. · Lin Y. · Liebsack C.
Neurodegenerative Dis 2010;7:183–186 (DOI:10.1159/000295660)
Free Access
187

Effect of Heparin on APP Metabolism and Aβ Production in Cortical Neurons

Klaver D. · Hung A.C. · Gasperini R. · Foa L. · Aguilar M.-I. · Small D.H.
Neurodegenerative Dis 2010;7:187–189 (DOI:10.1159/000295661)
190

Retinoids as a Perspective in Treatment of Alzheimer’s Disease

Fahrenholz F. · Tippmann F. · Endres K.
Neurodegenerative Dis 2010;7:190–192 (DOI:10.1159/000295662)
193

Treatment of Alzheimer’s Disease with a Cholinesterase Inhibitor Combined with Antioxidants

Cornelli U.
Neurodegenerative Dis 2010;7:193–202 (DOI:10.1159/000295663)
203

Filamentous Phages Reduce α-Synuclein Oligomerization in the Membrane Fraction of SH-SY5Y Cells

Dimant H. · Solomon B.
Neurodegenerative Dis 2010;7:203–205 (DOI:10.1159/000295664)
206

Effects of Dopamine Agonists on Neuropsychiatric Symptoms of Parkinson’s Disease

Rektorová I.
Neurodegenerative Dis 2010;7:206–209 (DOI:10.1159/000295665)
210

Future Strategies for Neuroprotection in Parkinson’s Disease

Schapira A.H.V.
Neurodegenerative Dis 2010;7:210–212 (DOI:10.1159/000295666)
213

The Concept of Continuous Dopaminergic Stimulation: What We Should Consider when Starting Parkinson’s Disease Treatment

Stocchi F.
Neurodegenerative Dis 2010;7:213–215 (DOI:10.1159/000295667)
Further Section
216

Author Index Vol. 7, No. 1–3, 2010

Neurodegenerative Dis 2010;7:216 (DOI:10.1159/000313306)
Free Access
217

Subject Index Vol. 7, No. 1–3 2010

Neurodegenerative Dis 2010;7:217–218 (DOI:10.1159/000313307)
Free Access